NFKB1 and marginal zone lymphoma: The L265P mutation of MYD88—which affects 3% of MZL patients—changes the structure of MYD88 to allow spontaneous homodimerisation and recruitment of serine threonine kinases IRAK1 and IRAK4 essential for NF-κB activation by the toll-like receptors [39].